Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended
	Apr. 30, 2019	Apr. 30, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances - February 1, 2018 (in shares)	1,233,853
Balances - February 1, 2019	$ (678,551)	$ (595,602)
Net loss	$ (18,641)	(20,148)
Balances - April 30, 2018 (in shares)	1,233,853
Balances - April 30, 2018	$ (697,192)	$ (615,750)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances - February 1, 2018 (in shares)	1,233,853	1,233,853
Balances - February 1, 2019	$ 1,233	$ 1,233
Balances - April 30, 2018 (in shares)	1,233,853	1,233,853
Balances - April 30, 2018	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances - February 1, 2019	81,323	81,323
Balances - April 30, 2018	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balances - February 1, 2019	(761,107)	(678,158)
Net loss	(18,641)	(20,148)
Balances - April 30, 2018	$ (779,748)	$ (698,306)